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ORIGINAL RESEARCH
Combining Optimized Image Processing 
With Dual Axis Rotational Angiography: 
Toward Low- Dose Invasive Coronary 
Angiography
Dimitri Buytaert , MSc; Benny Drieghe, MD; Frédéric Van Heuverswyn, MD; Jan De Pooter, MD, PhD;  
Peter Gheeraert, MD, PhD; Daniël De Wolf, MD, PhD; Yves Taeymans, MD, PhD; Klaus Bacher, PhD
BACKGROUND: Dual axis rotational coronary angiography (DARCA) reduces radiation exposure during coronary angiography 
on older x- ray systems. The purpose of the current study is to quantify patient and staff radiation exposure using DARCA on 
a modality already equipped with dose- reducing technology. Additionally, we assessed applicability of 1 dose area product to 
effective dose conversion factor for both DARCA and conventional coronary angiography (CCA) procedures.
METHODS AND RESULTS: Twenty patients were examined using DARCA and were compared with 20 age- , sex- , and body mass 
index–matched patients selected from a prior study using CCA on the same x- ray modality. All irradiation events are simulated 
using PCXMC (STUK, Finland) to determine organ and effective doses. Moreover, for DARCA each frame is simulated. Staff 
dose is measured using active personal dosimeters (DoseAware, Philips Healthcare, The Netherlands). With DARCA, median 
cumulative dose area product is reduced by 57% (ie, 7.41 versus 17.19 Gy·cm2). Effective dose conversion factors of CCA and 
DARCA are slightly different, yet this difference is not statistically significant. The occupational dose at physician’s chest, leg, 
and collar level are reduced by 60%, 56%, and 16%, respectively, of which the first 2 reached statistical significance. Median 
effective dose is reduced from 4.75 mSv in CCA to 2.22 mSv in DARCA procedures, where the latter is further reduced to 
1.79 mSv when excluding ventriculography.
CONCLUSIONS: During invasive coronary angiography, DARCA reduces radiation exposure even further toward low- dose values 
on a system already equipped with advanced image processing and noise reduction algorithms. For both DARCA and CCA 
procedures, using 1 effective dose conversion factor of 0.30 mSv·Gy−1·cm−2 is feasible.
Key Words: cardiac catheterization ■ contrast media ■ coronary angiography ■ dual axis rotational angiography ■ effective dose ■ 
radiation dosing ■ rotational angiography
Coronary artery disease is an important cause of morbidity and mortality. Numbers of coronary angiographies (CA) and percutaneous coronary 
interventions (PCI) are still rising.1,2 Diagnosis and treat-
ment of coronary artery disease requires x- ray guid-
ance during both CA and PCI. This may result in high 
radiation exposure levels for patients and staff, espe-
cially during complex interventions. Prevalence of lens 
opacities in interventionalists is increasing, supporting 
the hypothesis of increased risk of cataract in occupa-
tionally exposed personnel.3–5
Projection angiograms in conventional coronary an-
giography (CCA) result in vessel overlap, vessel fore-
shortening, and unappreciated tortuosity.6–8 Multiple 
studies report reduced radiation exposure during CA, 
using rotational angiography. The most recent type 
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of rotational angiography is dual axis rotational coro-
nary angiography (DARCA).9,10 This technology shows 
high potential for dose reduction, both for patients and 
staff, since the coronary tree can be completely visu-
alized using 2 rotations (ie, 1 for each coronary artery). 
Various studies show that DARCA reduces dose area 
product (DAP), air kerma, peak skin dose, scatter radi-
ation, contrast volume consumption, and acute kidney 
injury when compared with CCA.11–19
The goal of the current study was to quantify the 
potential reduction in radiation exposure for both pa-
tients and staff during invasive CA, by using DARCA on 
a modality that is already equipped with dose- reducing 
technology. To our knowledge this is the first study to 
simulate organ doses (OD) and effective doses (ED) 
for both CCA and DARCA procedures in patients. 
Furthermore, this is the first study in which staff expo-
sure is measured during clinical DARCA procedures 
instead of using phantom measurements.
METHODS
The data that support the findings of this study are 
available from the corresponding author upon reason-
able request.
Study Population
Twenty consecutive adult patients, referred for clinically 
indicated diagnostic cardiac catheterization of the cor-
onary arteries, were enrolled. CA for these 20 patients 
was performed using DARCA, and patient, operator, and 
staff radiation exposure levels were compared with 20 
age, sex, and body mass index–matched patients se-
lected from a prior study using CCA on the same equip-
ment.20 All 40 patients have thus been catheterized in 
the same catheterization laboratory. With matching, we 
aimed to equalize the age, sex, and body mass index 
distributions between both patient groups, yet cases 
were not individually matched.
Since the CCA procedures from the prior study were 
performed using femoral access, all DARCA procedures 
included in the current study were performed using fem-
oral access, to prevent biasing the results by access site. 
Patients with coronary artery bypass grafting were ex-
cluded. In case of a combined diagnostic and interven-
tional procedure, only data from the diagnostic part were 
retained for analysis and the PCI part was excluded from 
the current study. All patients gave their written informed 
consent to participate. The study protocol was approved 
by the Ethics Committee of Ghent University Hospital.
Imaging Modality
All procedures (ie, all CCA and DARCA procedures) were 
performed in the same catheterization laboratory using 
the same x- ray modality (AlluraClarity FD20/10, Philips 
CLINICAL PERSPECTIVE
What Is New?
• While dual-axis rotational coronary angiography 
(DARCA) already proved useful on older sys-
tems, the current study assesses the impact of 
DARCA for invasive coronary angiography on a 
system equipped with dose-reducing technol-
ogy that already demonstrated significant dose 
reductions in the recent past.
• Detailed estimation of organ and effective doses 
for each x-ray image frame of dual-axis coro-
nary angiograms of the left and right coronary 
artery were conducted.
• Organ doses, effective dose, and dose area 
product–to-effective dose conversion factors 
have been established for DARCA procedures, 
and operator exposure is measured during 
DARCA procedures using real-time dosimeters.
What Are the Clinical Implications?
• Also on x-ray modalities already equipped with 
dose-reducing technology, DARCA is able to 
significantly reduce radiation exposure for both 
patient and operator.
• Combining dose-reducing technology, in this 
case implemented as advanced image pro-
cessing and additional copper filtration, with 
DARCA enables low-dose invasive coronary 
angiography.
• Provided that the x-ray energy spectrum of the 
conventional coronary angiography and DARCA 
protocols are comparable, the same dose area 
product–to-effective dose conversion factors 
can be used for DARCA as for conventional 
coronary angiography procedures.
Nonstandard Abbreviations and Acronyms
CA   coronary angiography
CAD   coronary artery disease
CCA   conventional coronary angiography
CFDAP-ED   dose area product to effective dose 
conversion factor
CFDAP-OD   dose area product to organ dose 
conversion factor
DAP   dose area product
DARCA    dual-axis rotational coronary 
angiography
ED   effective dose
LCA   left coronary artery
OD   organ dose
PCI   percutaneous coronary intervention




 http://ahajournals.org by on A
ugust 4, 2020
J Am Heart Assoc. 2020;9:e014683. DOI: 10.1161/JAHA.119.014683 3
Buytaert et al Toward Low- Dose Invasive Coronary Angiography
Healthcare, Best, The Netherlands) equipped with both 
dose- reducing technology (ClarityIQ, Philips Healthcare, 
Best, The Netherlands) and DARCA technology 
(XperSwing, Philips Healthcare, Best, The Netherlands).
ClarityIQ combines powerful image processing, 
with optimized tube and detector settings to allow re-
duced dose settings without impairing clinical image 
quality.21
Figure  1. Graphical depiction of the C- arm movement during a DARCA acquisition of the left 
coronary artery.
The trajectory along which the C- arm moves during the acquisition is shown in (A). The acquisition starts 
at LAO40°- CAUD18° and can be split into 3 regions. Rows (B through D) each represent 1 region. For 
each region, the C- arm movement and a corresponding selection of 2 frames from an example DARCA 
angiogram are shown (B). The C- arm moves from an LAO to an RAO projection, while approximately 
maintaining the secondary projection angle constant in a caudal projection. C, Subsequently the C- arm is 
moved toward a cranial projection while keeping the primary angle roughly constant at an RAO projection 
and (D) eventually the C- arm travels back to an LAO projection while the secondary projection angle 
remains at an approximately constant cranial angle. Finally the acquisition ends at LAO25°- CRA25°. 
CAUD indicates caudal; CRA, cranial; DARCA, dual- axis rotational coronary angiography; LAO, left 
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In CCA, multiple coronary angiograms for each 
coronary artery (left and right) are acquired at different 
projection angles to visualize the complete coronary 
tree. For each projection angiogram, the C- arm is first 
moved manually to one of the desired projections by 
an operator. Subsequently a contrast media injection 
and x- ray acquisition are initiated by the interventional 
cardiologist, during which the C- arm will remain sta-
tionary. In the CCA procedures, a standard acquisition 
protocol based on local practice was implemented, as 
described previously, including a lateral acquisition of 
both the left coronary artery (LCA) and right coronary 
artery (RCA) and a ventriculogram of the left ventricle.22 
DARCA allows for visualization of the whole coronary 
tree using merely 2 cinegraphy acquisitions, 1 for each 
coronary artery, during which the C- arm automatically 
follows a preprogrammed trajectory. This trajectory is 
designed by the manufacturer such that the C- arm 
passes by the projections most commonly acquired 
during CCA, including the optimal projections visualiz-
ing the major coronary segments with minimal vessel 
foreshortening and overlap,11 in 1 continuous and auto-
mated movement and with a single contrast injection. 
Hence, the DARCA trajectory describes C- arm move-
ment around both the left anterior oblique- right anterior 
oblique (LAO- RAO) and caudal- cranial (CAUD-CRA) 
axes simultaneously, as opposed to single- axis rota-
tional angiography describing a circular motion within 
a single plane from LAO to RAO or vice versa while 
maintaining a constant orientation around the CAUD- 
CRA axis.9 The DARCA trajectory for the LCA applied 
in this study is described in Figure 1 together with sev-
eral frames of a resulting dual axis rotational coronary 
angiogram of the LCA. For the LCA, rotation starts at 
LAO40°- CAUD18° and ends at LAO25°- CRA25° after 
5.3 s. A video of the C- arm trajectory together with an 
example of a resulting angiogram is given as an online 
data supplement (Video S1). Similarly as for the LCA, 
a preprogrammed DARCA trajectory was available for 
the RCA, starting at RAO30°- CAUD25° and stopping 
at LAO30°- CRA30° after 3.7 s. The standard acquisi-
tion protocol for DARCA was 1 DARCA acquisition for 
each coronary artery (1 left and 1 right) and a ventricu-
logram of the left ventricle.
The system powers up with the lowest dose set-
tings as default. The cardiologists were requested to 
perform all procedures using these default settings. If 
necessary, cardiologists could acquire more projec-
tions and use higher dose settings. The lowest dose 
settings for the coronary protocols apply an additional 
beam filtration of 0.4  mm Cu+1  mm Al and a frame 
rate equal to 15 f/s in both the CCA protocols and the 
DARCA protocols. For the left ventricle protocol, 30 f/s 
is used with an additional 0.1 mm Cu+1 mm Al filtration. 
The tube has an inherent filtration of 2.5 mm Al and a 
tungsten anode at an 11° angle.
Contrast medium is administered using a contrast 
delivery system (ACIST CVi, Acist Medical Systems, 
Eden Prairie, MN). Contrast is automatically injected 
when x- ray acquisition is initiated. Selective DARCA 
angiograms of the LCA and RCA are acquired using a 
respective 2.1 and 1.2 mL/s contrast injection rate, and 
CCA angiograms apply 4 and 3 mL/s for the LCA and 
RCA respectively.
Patient Exposure Evaluation
The catheterization laboratory is equipped with DICOM 
Radiation Dose Structured Reports, containing cumu-
lative information about the patient’s radiation exposure 
for the whole procedure, as well as information per ir-
radiation event (ie, per fluoroscopy exposure and cine-
graphy acquisition). At the end of each procedure, they 
are sent to a dose management system (DoseWatch, 
GE Healthcare, Milwaukee, WI).
For each procedure the average peak tube potential 
or kVp is calculated as the weighted sum of kVp val-
ues for all irradiation events, where the weighting factor 
per irradiation event is calculated as the corresponding 
DAP for said irradiation event divided by the cumulative 
DAP for that procedure. This is shown in formula (1):
where i is 1 irradiation event. Likewise, average addi-
tional filtration is calculated per procedure. With the 
latter parameters, aforementioned anode angle and 
inherent filtration as input, half value layer is then esti-
mated using Spectrum Processor 3.0 for IPEM report 
78.23
Patient Organ and Effective Doses
OD and ED are calculated using PCXMC, a Monte Carlo 
simulations software. The 40 procedures included in 
this study account for 1122 irradiation events, of which 
each is simulated automatically using PCXMC, in- 
house scripts, and a customized database. Dose area 
product to organ dose conversion factors from DAP to 
OD (CFDAP-OD) and dose area product to effective dose 
conversion factor (CFDAP-ED) are determined.
The DARCA acquisitions are considered a sin-
gle irradiation event in the Radiation Dose Structured 
Reports, recording only the exposure parameters of 
the last frame. To calculate OD and ED of the DARCA 
acquisitions, the exposure parameters for each frame 
were estimated as follows. The manufacturer provided 
a look- up table demonstrating the automatic bright-
ness and exposure control response on our modal-
ity. This look- up table contains the tube voltage, tube 
current, pulse width, and air kerma rate for each mm 
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400  mm Water Equivalent Thickness. A mathemat-
ical PCXMC phantom is selected based on patient 
age and adjusted to the patient’s height and weight. 
Assuming that the heart is positioned at the isocenter 
of the C- arms, the patient thickness was calculated 
for each C- arm projection during the DARCA acqui-
sition. From these thicknesses, the Water Equivalent 
Thickness was calculated by applying a single con-
version factor, per DARCA acquisition, from phantom 
thickness to Water Equivalent Thickness. The latter 
conversion factor was numerically determined as the 
conversion factor that resulted in the minimal devia-
tion of the air kerma for 1 DARCA acquisition obtained 
from the look- up table and the air kerma for the same 
DARCA acquisition obtained from the Radiation Dose 
Structured Reports. In total 5680 DARCA frames were 
simulated using PCXMC.
Occupational Exposure Evaluation
Occupational dose was measured using the 
DoseAware Xtend system (Philips Healthcare, Best, 
The Netherlands). The latter system consists of a set of 
calibrated solid- state active personal dosimeters, log-
ging the cumulative personal dose equivalent Hp(10) 
every second via a wireless base station. Hp(10) is 
an operational quantity for personal monitoring, de-
fined as the dose equivalent to soft tissue at a depth 
of 10 mm below a specified point on the body (ie, the 
point where the dosimeter is worn). The latter param-
eter can be used to assess ED.24 The characteristics 
of these dosimeters were described previously.25 This 
system automatically sends staff dose data, in DICOM 
format, as an operator dose structured report, contain-
ing cumulative doses and mean dose rates per proce-
dure, and per irradiation event, for each active personal 
dosimeter that was inside the catheterization laboratory 
during the procedure.
A set of 5 active personal dosimeters was used and 
worn above the lead apron. The physician’s set con-
tains 1 collar, and chest (breast pocket) and leg (left 
knee level) dosimeter. The technologists wore a col-
lar and chest active personal dosimeter. The staff was 
blinded for their dosimeter readings.
Statistical Analysis
For normally distributed variables, significance testing 
of differences between CCA and DARCA was per-
formed using an independent samples t test with a 
95% 2- sided CI. A Mann–Whitney test was performed 
in case of non-normality. Variables were summarized 
using median, 25th percentile (Q1), and 75th percentile 
(Q3). Comparison of categorical parameters was done 
using a χ2 test for association, also applied with a 95% 
CI. All statistical analyses were performed using IBM 
SPSS Statistics 25 (IBM Corp, Armonk, NY).
Correlation between DAP and OD and between 
DAP and ED was assessed using linear regression. 
CFDAP-OD and CFDAP-ED are determined as the slope co-
efficient of a linear regression analysis.
RESULTS
Patient Exposure Evaluation
An overview of patient radiation exposure is given in 
Table  1. Concerning patient demographics, no dif-
ferences are noted. Regarding patient exposure, for 
all parameters except fluoroscopy DAP, fluoroscopy 
time, and CFDAP-ED, statistically significant differences 
are observed. Total DAP and air kerma per procedure 





P ValueMedian (Q1–Q3) Median (Q1–Q3)
Demographic patient data
Males/females 9/11 11/9 0.527
Age, y 71.5 (59.0–78.3) 68.0 (64.3–71.0) 0.975
BMI, kg/m² 26.6 (23.5–28.1) 27.8 (25.5–31.8) 0.079
Exposure parameters
DAP total, Gy·cm² 7.41 (5.04–9.10) 17.19 
(11.06–22.47)
<0.0005
DAP fluoro, Gy·cm² 3.17 (2.89–5.73) 3.95 (2.62–5.55) 0.495
DAP exposure, 
Gy·cm²
3.22 (2.38–5.00) 10.73 (8.73–16.45) <0.0005





Cine runs, n 3.0 (3.0–4.0) 11.5 (10.3–12.0) <0.0005
Exposure images, 
n
316 (278–385) 826 (749–913) <0.0005
Fluoroscopy 
time, s
117 (93–158) 125 (100–147) 0.448
Fluoroscopy 
portion, %
51 (40–63) 26 (22–30) <0.0005




20 (13–34) 50 (24–92) 0.007
Physician collar, 
μSv
21 (13–43) 25 (8–41) 0.841
Physician leg, μSv 42 (32–63) 97 (60–141) 0.004
Technician torso, 
μSv
2 (1–3) 3 (2–6) 0.068
Technician collar, 
μSv
2 (1–5) 2 (1–5) 0.738
Values are reported as median (Q1–Q3), where Q1 and Q3 are, 
respectively, the first and third quartiles. BMI indicates body mass 
index; CA, coronary angiography; CMC, contrast media consumption; 
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are reduced by 57% (P<0.0005) and 59% (P<0.0005), 
respectively. Number of cinegraphy exposures and 
exposure images are, respectively, 74% (P<0.0005) 
and 70% (P<0.0005) lower for DARCA procedures 
compared with CCA examinations. Exposure DAP is 
70% lower in DARCA procedures (P<0.0005). Contrast 
media consumption is reduced by 35% when apply-
ing DARCA (P<0.001). Although the use of higher dose 
settings was allowed when the default protocols did 
not suffice, only the default low- dose protocols were 
used in both the CCA and DARCA groups. Contrast 
media consumption amounts on average 7 and 6 mL 
for CCA projections of the LCA and RCA, respectively, 
and for DARCA the values are, respectively, 13 and 
7 mL.
All procedures in this study include an acquisition of 
the left ventricle. When ventriculography is excluded, 
total DAP is equal to 5.46 (4.25–7.89) and 13.04 (9.59–
18.49) Gy·cm2 for DARCA and CCA procedures, re-
spectively. Contribution of the left ventricle cinegraphy 
exposure to total DAP is equal to 16% in CCA proce-
dures and 23% in DARCA procedures. Lateral acqui-
sitions are known to result in high radiation exposure, 
are absent from both DARCA trajectories, and are 
therefore absent from DARCA procedures. Excluding 
both left ventricle and lateral acquisitions from the CCA 
procedures resulted in a DAP of 10.56 (8.16–15.69) 
Gy·cm2. After excluding the latter acquisitions, DAP 
in DARCA procedures is still significantly lower than in 
CCA procedures (P<0.0005).
Average kVp and additional filtration is 87 kVp 
and 0.97  mm Al+0.34  mm Cu in CCA procedures 
and 85 kVp and 1.00 mm Al+0.34 mm Cu in DARCA 
procedures, resulting in a half value layer of 7.15 
and 7.25  mm Al for the CCA and DARCA groups, 
respectively. The small differences in tube voltage 
(P=0.602), additional Al filtration (P=0.512), and Cu 
filtration (P=0.414) were not statistically significant. 
This verifies that indeed the same dose settings were 
used in both groups, and that there was no signifi-
cant difference in patient thickness between the CCA 
and DARCA groups.
Figure  2 shows the DARCA trajectories followed 
by the C- arm for both the LCA and RCA on top of a 
2- dimensional histogram displaying the most used C- 
arm projections for cinegraphy during CCA.
As C- arm x- ray modalities are equipped with an au-
tomatic exposure control, the radiation output of the x- 
ray tube is adjusted continuously to keep the radiation 
dose rate at the detector level constant. With DARCA, 
the projection varies during the acquisition, meaning 
a different patient attenuation is encountered for each 
frame. Hence, DAP significantly varies during the ac-
quisition, which is shown in Figure 3A and 3C for the 
DARCA protocol of the LCA and RCA, respectively.
Patient Organ and Effective Doses
OD and ED are reported in Table  2. The table also 
displays between parentheses the average contribu-
tion of the organ to the total ED. Remainder organs 
include adrenals, extrathoracic airways, gallbladder, 
heart, kidneys, lymphatic nodes, muscle, oral mucosa, 
pancreas, prostate (male), small intestine, spleen, thy-
mus, and uterus (female) according to International 
Commission on Radiological Protection publication 
103. Although the heart is included in the remainder 
organs, heart OD was also assessed separately. OD in 
all organs is lower with DARCA compared with CCA. 
The lungs have the largest contribution to the total ED 
per procedure, accounting for on average 44% of total 
ED. When excluding the ventriculography at the end 
of the examination, ED further reduces to 4.18 (2.79–
4.91) and 1.79 (1.46–2.84) mSv in the CCA and DARCA 
groups, respectively. When excluding the left ventri-
cle and lateral acquisitions for CCA procedures, ED 
equals 3.34 (2.39–4.14) mSv, which remains a higher 
value than ED in DARCA procedures (P<0.0005). DAP 
to OD (CFDAP-OD) and ED conversion factors (CFDAP-ED) 
are tabulated in Table 3.
Median (Q1- Q3) DAP for the left and right DARCA 
protocol is, respectively, equal to 0.84 (0.63–0.96) 
and 0.77 (0.60–0.90) Gy·cm2, ED for the left and right 
DARCA protocol is, respectively, equal to 0.36 (0.25–
0.45) and 0.23 (0.20–0.27) mSv, and CFDAP-ED for the 
left and right DARCA protocol is, respectively, equal to 
0.29 (0.27–0.30) and 0.29 (0.27–0.32) mSv·Gy−1·cm−2. 
Figure 2. Conventional projections and DARCA trajectori es. 
The solid and dashed curves indicate the C-arm trajectory 
followed during DARCA acquisition of the LCA and RCA 
respectively. The shaded areas in the background show a 
2- dimensional histogram of the cinegraphy projection angles 
used during CCA. Darker regions indicate more frequent 
projections. Projection angles within the white background 
are never applied. CAUD indicates caudal; CCA, conventional 
coronary angiography; CRA, cranial; DARCA, dual- axis rotational 
coronary angiography; LAO, cranial; LCA, left coronary artery; 
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OD and consequently ED are directly proportional to 
the DAP. Therefore, ED varies accordingly for each 
frame along the trajectory, following a similar trend 
as the DAP. This is shown in Figure 3A and 3C. The 
frames with the largest ED are the 45th and 39th frame 
of the left and right DARCA protocol, respectively, cor-
responding to RAO40°- CAUD0° and LAO40°- CRA9° 
C- arm projections. Additionally, the frames with the 
highest DAP do not necessarily yield the highest radia-
tion detriment and risk; this is highly dependent on the 
Figure 3. Patient exposure per DARCA frame.
A, DAP end ED per DARCA for the LCA. The left and right vertical axis show the respective DAP and ED ranges. B, Conversion factor 
from DAP to ED for each DARCA frame of the LCA. C, DAP and ED per DARCA frame for the RCA. The left and right vertical axis show 
the respective DAP and ED ranges. D, Conversion factor from DAP to ED for each DARCA frame of the RCA. ED indicates effective dose; 
DAP, dose area product; DARCA, dual- axis rotational coronary angiography; LCA, left coronary artery; and RCA, right coronary artery.
Table 2. Organ and Effective Dose
DARCA (n=20) CCA (n=20)
P ValueMedian (Q1–Q3) Median (Q1–Q3)
Organ doses, mGy
Stomach (5.49%) 0.99 (0.8–1.44) 2.14 (1.59–2.76) <0.0005
Liver (3.74%) 1.97 (1.36–3.23) 4.05 (2.81–5.93) <0.0005
Lungs (44.26%) 7.37 (6.01–12.66) 17.49 (11.57–19.91) <0.0005
Breasts (11.4%) 1.68 (1.23–3.4) 4.2 (3.1–4.47) 0.003
Esophagus (10.27%) 5.39 (4.57–8.21) 11.75 (8.79–14.55) <0.0005
Remainder (9.94%) 1.74 (1.44–2.59) 4.34 (3.2–5.71) <0.0005
Active bone marrow (12.31%) 2.31 (1.73–2.98) 4.86 (3.59–6.25) <0.0005
Heart (3.22%) 7.28 (6.04–12.7) 15.78 (11.07–19.89) <0.0005
Effective dose, mSv 2.22 (1.78–3.2) 4.75 (3.29–5.73) <0.0005
Organ doses (mGy) of various organs and effective dose (mSv) in DARCA and CCA procedures. The average contribution of the organ’s equivalent tissue 
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applied projection, yet the course of the CFDAP-ED vari-
ation during a DARCA acquisition describes a shape 
similar to that of DAP and ED. The frames with the 
highest ED also present the highest CFDAP-ED. This is 
displayed in Figure 3B and 3D.
Occupational Exposure Evaluation
Occupational exposure is also summarized in Table 1. 
The physician’s occupational dose is reduced by 
60%, 16%, and 56% at chest, collar, and leg level, 
respectively, in DARCA examinations. The difference 
at collar level, however, is not statistically significant. 
No statistically significant differences are observed for 
the technician’s occupational dose.
DISCUSSION
The results show that DARCA improved procedure 
safety by significantly reducing contrast media con-
sumption and patient and operator radiation exposure 
compared with CCA. Since the same x- ray modality al-
ready demonstrated significant dose reduction by im-
plementing noise reduction algorithms and additional 
filtration, introducing DARCA resulted in low- dose inva-
sive CA procedures. Furthermore, we have shown that 
from DAP, displayed on most C- arm x- ray modalities, 
ED can be estimated using the same conversion factor 
for both DARCA and CCA procedures.
Patient Exposure Evaluation
Patient exposure reduction can mainly be attributed to 
the reduced number of cinegraphy acquisitions (11.5 
for CCA versus 3.0 for DARCA, ie, 74%). However, 
the number of exposure images is only 62% lower for 
DARCA procedures. The trajectories in Figure 2 imply 
complete absence of lateral acquisitions (LAO90°- 
CAUD0°) during DARCA procedures, while during 
CCA 1 lateral angiogram is acquired for each coro-
nary artery. Lateral acquisitions result in higher DAP 
per frame. Hence, with 62% fewer exposure images 
in DARCA, a 70% lower exposure DAP still is reached.
Several studies compared CCA and DARCA 
in terms of DAP and contrast volume (Table  4). 
Table 3. CFDAP-OD and CFDAP-ED
DARCA (n=20) CCA (n=20)
P ValueSlope (LL- UL) Slope (LL- UL)
CFDAP-OD, mGy/Gy·cm
2
Stomach 0.14* (0.13–0.15) 0.13* (0.12–0.14) 0.382
Liver 0.28* (0.22–0.34) 0.27* (0.23–0.31) 0.757
Lungs 1.11* (0.99–1.22) 0.99* (0.91–1.07) 0.135
Breasts 0.27* (0.19–0.35) 0.24* (0.19–0.3) 0.653
Esophagus 0.79* (0.74–0.83) 0.67* (0.63–0.72) 0.004
Remainder 0.25* (0.23–0.26) 0.26* (0.24–0.27) 0.478
Active bone 
marrow
0.31* (0.29–0.32) 0.29* (0.27–0.3) 0.074
Heart 1.12* (1.04–1.19) 0.93* (0.87–0.98) 0.001
CFDAP-ED, 
mSv/Gy·cm²
0.30* (0.27–0.33) 0.27* (0.25–0.29) 0.193
CCA indicates conventional coronary angiography; CFDAP-ED, DAP to 
effective dose conversion factor; CFDAP-OD, DAP to organ dose conversion 
factor; DAP, dose area product; DARCA, dual- axis rotational coronary 
angiography; LL, lower limit of the 95% CI; and UL, upper limit of the 95% CI.
*Results of the linear regression analysis between DAP and either organ or 
effective doses. The slope coefficients are the conversion factors.
Table 4. DAP and CMC in Literature Comparing CCA and DARCA
Reference
CCA DARCA
DAP (Gy·cm2) CMC (mL) DAP (Gy·cm2) CMC (mL)
Klein (2011)11 38.0±11.5 38.8±14.9 23.8±6.2 17.9±2.3
Grech (2012)12
Monoplane 32.7±17.8 38.1±11.3 22.0±16.3 22.5±9.2
Biplane 56.7±28.6 27.8±10.8 30.9±18.5 24.4±7.7
Gomez- Menchero (2012)13 27.6±11.5 93.1±41.7 18.0±6.4 50.9±14.7
Liu (2012)14 21.2±8.2 51.7±10.3 9.5±4.1 29.9±6.0
Yasar (2013)15 66.7±48.7 70.9±24.8 34.2±23.8 54.4±26.9
Farshid (2014)16 30.4±18.7 41.7±11.9 15.9±11.3 25.7±8.1
Giuberti (2014)17 30.0 (20.9–37.4) 76.0 (68.0–87.0) 20.0 (13.2–29.2) 60.0 (52.5–71.5)
Di Serafino (2018)18 ··· 80 (50–150) ··· 40 (31–116)
Current study (2019)
Including all acquisitions 17.2 (11.1–22.5) 109.3 (99.3–120.9) 7.4 (5.1–9.1) 71.0 (62.5–80.6)
Excluding left ventricle 13.0 (9.6–18.5) 79.3 (69.4–89.2) 5.5 (4.3–7.9) 43.7 (33.8–57.3)
Excluding left ventricle and lateral 10.6 (8.2–15.7) 66.3 (56.4–76.2) 5.5 (4.3–7.9) 43.7 (33.8–57.3)
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Compared with literature referenced in Table 4, the 
lowest DAP values are observed in the current study 
for both CCA and DARCA procedures. This is be-
cause of the availability of ClarityIQ technology. The 
x- ray modalities from the references in Table  4 are 
not equipped with the latter technology. Also, all pro-
cedures in the current study were performed using 
femoral access, while 4 out of 8 literature references 
applied radial access.12–14,18 Some studies report a 
small but statistically significant increase using the 
radial approach compared with femoral access.26 
When PCI was indicated after DARCA or CCA, PCI 
was allowed during the same procedure, but only the 
data from the diagnostic part of the procedure were 
registered and analyzed. DARCA was not applied 
during the PCI part and cannot be applied during PCI 
since stationary acquisitions are needed; however, 
it helps in selecting the optimal projection for PCI. 
Therefore, as far as we know, there have not been 
any reports in the literature of DARCA being applied 
during PCI procedures. Only 3 out of 20 DARCA and 
1 out of 20 CCA procedures were followed by PCI 
in the same procedure, hence the effect of DARCA 
during the diagnostic part on the PCI part could not 
be examined. Gómez- Menchero et al assessed the 
impact of DARCA on combined diagnostic and ther-
apeutic procedures and recorded a 29% contrast 
medium volume reduction without any statistically 
significant radiation dose reduction when compared 
with the conventional technique.13
Averaged over all previous publications (Table  4), 
DAP was reduced by 42% because of DARCA, while 
in the current study DAP was reduced by 57%. The 
more pronounced reduction in DAP in our study can 
be explained by either a larger number of views ac-
quired during CCA or slightly shorter DARCA acquisi-
tions (Table 5).
On the contrary, contrast media consumption in 
the current study is higher than the previous studies. 
However, this can be attributed to the ventriculography 
at the end of each procedure, which consumes 30 mL 
of contrast media that was included in our study and 
not in previous studies mentioned in Tables 4 and 5. 
When excluding the acquisition of the left ventricle from 
the analysis, contrast volume is comparable with val-
ues found in the literature.
The current study achieves among the lowest 
patient exposures for invasive coronary angiogra-
phy.27,28 Kuon et  al still observe significantly lower 
values, with both state- of- the- art flat detector and 
older image intensifier systems.29 The latter study 
analyzed the impact of radiation- reducing strate-
gies, implemented by 1 senior highly experienced 
interventionalist over a period of 15  years, starting 
at 33.8  Gy·cm2 and ultimately accomplishing an 
impressive 0.6  Gy·cm2 for CCA. Examples of such 
radiation- reducing strategies are focusing on essen-
tial acquisitions and beam- on time, avoiding steep 
angulations, reducing frame rate, reducing detector 
dose, etc. Because cardiac departments generally 
use multiple interventionalists and technologists with 
varying experience, as in the current study, the latter 
DAP values of Kuon et al do not resemble standard 
clinical practice. However, they can be used as real-
izable benchmarks for individual performance when 
identical x- ray exposure settings are used. In our de-
partment, baseline DAP with reference technology 
was 57.56 Gy·cm2, which was reduced by introduc-
ing technology with additional filtration and advanced 
noise reduction algorithms to a value of 20.45 Gy·cm2 
for CCA procedures and combined CCA+PCI proce-
dures.20 In the current study we only retained CCA 
procedures, hence the lower 17.19 Gy·cm2 observed 
here, compared with the former 20.45  Gy·cm2 on 
the same system. Introducing DARCA yields a DAP 
value of 7.41 Gy·cm2, ie, a 9.78 Gy·cm2 (57%) reduc-
tion compared with CCA using the same equipment 
(P<0.0005).
Patient Organ and Effective Doses
In Table  3 the esophagus and heart exhibit a sta-
tistically different CFDAP-OD for CCA compared with 
DARCA. This might be attributed to a more uniform 
deposition of the dose in these organs during DARCA 
procedures. Respectively, the heart and esophagus 
are completely and almost completely exposed to 
the direct beam of all exposures. By using a limited 
Table 5. Number of Views During CCA of the LCA and RCA 








LCA RCA LCA RCA
Klein (2011)11 4 2 6.7 4.0
Grech (2012)12
Monoplane 5 2 5.3 3.7
Biplane 6 (=3×2) 2 5.3 3.7
Gomez- Menchero 
(2012)13
3 2 5.8 4.0
Liu (2012)14 5 2 5.8 4.0
Yasar (2013)15 4 2 ··· ···
Farshid (2014)16 4 to 5 2 to 3 5.8 3.7
Giuberti (2014)17 4 2 to 3 5.8 4.1
Di Serafino (2018)18 3 to 6 2 ··· 2 CCA views
Current study 
(2019)
6 3 5.3 3.7
CCA indicates conventional coronary angiography; DARCA, dual- axis 
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number of projections during CCA, the dose deposi-
tion might result in dose outliers within the volume 
of the directly exposed organs. This might have a 
different influence on the average organ dose than 
a continuous trajectory of projections as applied by 
DARCA, resulting in a more uniform dose distribu-
tion. Other organs are only partially exposed by the 
direct beam, resulting in nonuniform dose distribu-
tions for both CCA and DARCA procedures.
None of the references in Table  4 calculated OD 
and ED for CCA and DARCA. Several other studies 
provide either OD, ED, CFDAP-OD, CFDAP-ED, or a com-
bination of them obtained by Monte Carlo simulations 
using PCXMC for CCA and PCI procedures. Varghese 
et al reported mean DAP and ED values per projection 
for standard CCA procedures including 9 angiographic 
projections.30 Summing DAP and ED over all projec-
tions results in 17.14  Gy·cm2 and 4.93  mSv, respec-
tively. Hence a CFDAP-ED of 0.29  mSv·Gy
−1·cm−2 can 
be estimated from their study. Brambilla et al demon-
strated an identical CFDAP-ED as in the current study, 
(ie, 0.30 mSv·Gy−1·cm−2). They were also able to cal-
culate OD and ED in CA and PCI procedures, taking 
into account all irradiation events. Only 2 isocenters 
were considered, 1 for male and 1 for female. This 
study adjusts the mathematical phantom dimensions 
and isocenter positions according to the patient’s age 
and size, for each irradiation event, yielding a more ac-
curate resemblance to reality. They note higher organ 
doses and similar CFDAP-OD when compared with the 
current study because of their higher DAP and quite 
comparable CFDAP-OD, except for the breasts.
31 Eloot 
et al simulated single- axis rotational angiography ac-
quisitions in steps of 5°, evenly distributing DAP across 
the arc. Automatic brightness and exposure control 
was not taken into account. They observed a CFDAP-ED 
of 0.183  mSv·Gy−1·cm−2 for CCA procedures and a 
similar 0.179  mSv·Gy−1·cm−2 for single axis rotational 
coronary angiography procedures. Likewise, in the 
current study CFDAP-ED shows no statistically significant 
difference between CCA and DARCA examinations. 
Organ doses documented by Eloot et al are higher be-
cause of the higher DAP values in their study.22
To our knowledge only Wielandts et  al, besides 
the current study, calculated OD and ED of rotational 
angiography on a per- frame basis accounting for the 
automatic brightness and exposure control. The latter 
study involved ablation procedures, with single- axis 
rotational angiography acquisition of the region (atria 
or left ventricle) of interest. Frame- specific information 
was available in their system’s log files. No correlation 
was found between DAP and either OD or ED, hence 
no CFDAP-ED could be determined. This was attributed 
to the limited tube output resulting in unexpected, al-
most body mass index independent, behavior of the 
automatic brightness and exposure control.32
Occupational Exposure Evaluation
In 1 of our previous studies we tabulated Hp(10) val-
ues found in the literature.20 Hp(10) values observed 
by Brasselet et al, Lo et al, and Tsapaki et al are still 
lower than the values in the current study for DARCA 
procedures; notwithstanding they documented higher 
DAP values.33–35 This can be attributed to the use of 
additional radioprotective measures, such as ceiling 
suspended leaded glass, in the latter studies. Our cur-
rent and previous studies did not apply such devices 
to prevent operator- dependent use of shielding and to 
inhibit collision of the C- arm with radioprotective tools 
during rotational angiography.
For the technician’s exposure, no differences were 
observed between CCA and DARCA procedures. This 
might be attributed to the fact that they do not occupy 
a fixed position in the catheterization laboratory. They 
are continuously on the move. Since DARCA proce-
dures need significantly fewer acquisitions, it seems 
reasonable that they spend relatively more time ta-
bleside while x- ray exposure is active during DARCA 
procedures than during CCA procedures, which even-
tually annihilates the effect of the DAP reduction on the 
technician’s occupational exposure.
The physician’s collar dosimeter recorded a 
smaller exposure reduction than the leg and chest 
dosimeter. Also here, movement of the dosimeter 
introduces higher uncertainty of the recorded dose 
because this is the most mobile of the 3 physician’s 
dosimeters (ie, turning and/or tilting the head left or 
right results in significant change in position and ori-
entation of the collar dosimeter). Since a dosimeter’s 
position has a huge impact on the recorded dose, 
cf. the inverse square law, interpretation of the mea-
sured exposure is more reliable when including a 
recording of the dosimeter’s position, which should 
be addressed in future research. Additionally, during 
CCA procedures the imaging detector is positioned 
as close as possible to the patient to minimize ra-
diation exposure to the patient. This could block 
part of the scatter radiation to the collar dosimeter 
in posteroanterior, caudal, and right caudal projec-
tions (RAO≥0°- CAUD≥0°). Meanwhile, for DARCA 
acquisitions the source- to- imaging- detector dis-
tance is fixed at the largest distance (120  cm) to 
avoid collision with the patient, leaving a larger gap 
for the scatter radiation to reach the collar dosim-
eter. Furthermore, the caudal projections applied 
during CCA procedures are steeper compared with 
DARCA procedures.
CONCLUSIONS
The x- ray modality used in this study has already dem-




 http://ahajournals.org by on A
ugust 4, 2020
J Am Heart Assoc. 2020;9:e014683. DOI: 10.1161/JAHA.119.014683 11
Buytaert et al Toward Low- Dose Invasive Coronary Angiography
with reference technology by implementing advanced 
image processing and noise reduction algorithms and 
adding extra filtration during fluoroscopy and cinegra-
phy exposures. Applying DARCA in invasive CA pro-
cedures reduces the dose even further toward low 
dose values. For both DARCA and CCA procedures, 
1 CFDAP-ED of 0.30 mSv·Gy
−1·cm−2 is appropriate and 
can be considered as a robust DAP to ED conversion 
factor for modern catheterization laboratories.
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